3042.TW | TXC Corporation Annual & Quarterly Balance

Annual Balance Sheets

(In TWD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	18.82 Billion	19.85 Billion	20.8 Billion	16.6 Billion	13.36 Billion	12.56 Billion
Total Current Assets	10.81 Billion	11.41 Billion	11.36 Billion	10 Billion	7.94 Billion	7.11 Billion
Cash And Short Term Investments	4.92 Billion	4.99 Billion	4.48 Billion	3.37 Billion	2.81 Billion	2.39 Billion
Cash and Cash Equivalents	4.3 Billion	4.22 Billion	3.63 Billion	2.68 Billion	1.98 Billion	1.3 Billion
Short Term Investments	619.05 Million	769.42 Million	856.21 Million	695.58 Million	832.02 Million	1.09 Billion
Net Receivables	3.31 Billion	3.62 Billion	4.11 Billion	3.61 Billion	2.93 Billion	2.84 Billion
Inventory	2.46 Billion	2.69 Billion	2.63 Billion	2.81 Billion	2.03 Billion	1.81 Billion
Other Current Assets	109.19 Million	98 Million	123.47 Million	192.63 Million	149.1 Million	55.9 Million
Total Non-Current Assets	8.01 Billion	8.43 Billion	9.43 Billion	6.59 Billion	5.42 Billion	5.44 Billion
Net PPE	6.31 Billion	6.62 Billion	6.54 Billion	4.9 Billion	4.15 Billion	4.11 Billion
Good Will And Intangible Assets	50.79 Million	53.83 Million	51.89 Million	41.68 Million	27.81 Million	21.83 Million
Good Will	-	-	-	-	-	-
Intangible Assets	50.79 Million	53.83 Million	51.89 Million	41.68 Million	27.81 Million	21.83 Million
Long-Term Investments	1.56 Billion	351.71 Million	1.42 Billion	550.7 Million	133.92 Million	-170.85 Million
Tax Assets	67.3 Million	61.27 Million	49.97 Million	39.89 Million	39.34 Million	36.57 Million
Other Non Current Assets	9.68 Million	1.35 Billion	1.36 Billion	1.06 Billion	1.07 Billion	1.44 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	6.86 Billion	7.37 Billion	8.04 Billion	6.94 Billion	4.67 Billion	3.81 Billion
Total Current Liabilities	4.76 Billion	4.33 Billion	4.89 Billion	5.09 Billion	2.79 Billion	2.08 Billion
Account Payables	1.41 Billion	1.2 Billion	2.09 Billion	1.95 Billion	1.65 Billion	1.32 Billion
Tax Payables	-	204.05 Million	330.38 Million	117.05 Million	48.13 Million	3.64 Million
Short Term Debt	2.12 Billion	1.4 Billion	932.87 Million	918.02 Million	276.43 Million	169.73 Million
Deferred Revenue	40 Thousand	40 Thousand	1.84 Billion	1.81 Billion	779.61 Million	3.64 Million
Other Current Liabilities	1.22 Billion	1.71 Billion	21.11 Million	413.74 Million	81.3 Million	588.55 Million
Total Non Current Liabilities	2.1 Billion	3.04 Billion	3.14 Billion	1.85 Billion	1.87 Billion	1.72 Billion
Long-Term Debt	1.88 Billion	2.7 Billion	2.85 Billion	1.68 Billion	1.64 Billion	1.48 Billion
Deferred Revenue Non Current	79.31 Million	108.19 Million	70.77 Million	63.56 Million	74.03 Million	68.03 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	27.29 Million	106.73 Million	132.27 Million	36.12 Million	36.48 Million	26.15 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	11.87 Billion	12.47 Billion	12.75 Billion	9.65 Billion	8.69 Billion	8.75 Billion
Stock Holders Equity	11.87 Billion	12.47 Billion	12.75 Billion	9.65 Billion	8.69 Billion	8.75 Billion
Common Stock	3.09 Billion	3.09 Billion	3.09 Billion	3.09 Billion	3.09 Billion	3.09 Billion
Retained Earnings	5.22 Billion	5.86 Billion	5.18 Billion	3.23 Billion	2.78 Billion	2.67 Billion
Accumulated other comprehensive income	2.94 Billion	2.88 Billion	3.85 Billion	2.7 Billion	2.19 Billion	2.36 Billion
Common Stock Equity	11.87 Billion	12.47 Billion	12.75 Billion	9.65 Billion	8.69 Billion	8.75 Billion
Capital Lease Obligation	6.71 Million	6.48 Million	7.73 Million	2.94 Million	6.03 Million	-
Total Investments	2.18 Billion	1.12 Billion	2.27 Billion	1.24 Billion	965.95 Million	921.6 Million
Total Debt	4.01 Billion	4.11 Billion	3.78 Billion	2.6 Billion	1.91 Billion	1.65 Billion
Net Debt	-290.95 Million	-105.71 Million	153.59 Million	-77.22 Million	-69.21 Million	346.67 Million

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	21.6 Billion	19.79 Billion	18.82 Billion	18.82 Billion	18.59 Billion	19.1 Billion
Total Current Assets	12.77 Billion	11.51 Billion	10.81 Billion	10.81 Billion	10.28 Billion	10.9 Billion
Cash And Short Term Investments	6.57 Billion	5.61 Billion	4.92 Billion	4.92 Billion	4.25 Billion	5.59 Billion
Cash and Cash Equivalents	5.74 Billion	4.23 Billion	4.3 Billion	4.3 Billion	3.52 Billion	4.5 Billion
Short Term Investments	829.82 Million	1.38 Billion	619.05 Million	619.05 Million	729.6 Million	1.09 Billion
Net Receivables	3.16 Billion	3.05 Billion	3.31 Billion	3.31 Billion	3.54 Billion	2.67 Billion
Inventory	2.84 Billion	2.66 Billion	2.46 Billion	2.46 Billion	2.38 Billion	2.52 Billion
Other Current Assets	190.77 Million	186.69 Million	109.19 Million	109.19 Million	114.21 Million	110.25 Million
Total Non-Current Assets	8.82 Billion	8.27 Billion	8.01 Billion	8.01 Billion	8.3 Billion	8.2 Billion
Net PPE	7.11 Billion	6.54 Billion	6.31 Billion	6.31 Billion	6.47 Billion	6.35 Billion
Good Will And Intangible Assets	43.65 Million	46.44 Million	50.79 Million	50.79 Million	51.93 Million	52.16 Million
Good Will	-	-	-	-	-	-
Intangible Assets	43.65 Million	46.44 Million	50.79 Million	50.79 Million	51.93 Million	52.16 Million
Long-Term Investments	1.6 Billion	-347.2 Million	1.56 Billion	1.56 Billion	423.52 Million	95.35 Million
Tax Assets	44.67 Million	47.91 Million	67.3 Million	67.3 Million	47.21 Million	46.02 Million
Other Non Current Assets	17.59 Million	1.98 Billion	9.68 Million	9.68 Million	1.31 Billion	1.65 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	9.43 Billion	7.07 Billion	6.86 Billion	6.86 Billion	6.85 Billion	8.22 Billion
Total Current Liabilities	6.04 Billion	4.27 Billion	4.76 Billion	4.76 Billion	4.53 Billion	5.49 Billion
Account Payables	1.44 Billion	1.35 Billion	1.41 Billion	1.41 Billion	1.21 Billion	892.42 Million
Tax Payables	131.57 Million	-	-	-	-	124.21 Million
Short Term Debt	1.8 Billion	1.93 Billion	2.12 Billion	2.12 Billion	2.26 Billion	1.24 Billion
Deferred Revenue	42 Thousand	923.44 Million	40 Thousand	40 Thousand	1 Billion	3.32 Billion
Other Current Liabilities	2.79 Billion	58.35 Million	1.22 Billion	1.22 Billion	61.68 Million	42.69 Million
Total Non Current Liabilities	3.39 Billion	2.79 Billion	2.1 Billion	2.1 Billion	2.32 Billion	2.72 Billion
Long-Term Debt	3.22 Billion	2.46 Billion	1.88 Billion	1.88 Billion	2.01 Billion	2.48 Billion
Deferred Revenue Non Current	63.19 Million	72.89 Million	79.31 Million	79.31 Million	92.25 Million	87.18 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	46.16 Million	111.96 Million	27.29 Million	27.29 Million	105.42 Million	108.7 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	12.1 Billion	12.72 Billion	11.87 Billion	11.87 Billion	11.73 Billion	10.88 Billion
Stock Holders Equity	12.03 Billion	12.72 Billion	11.87 Billion	11.87 Billion	11.73 Billion	10.88 Billion
Common Stock	3.09 Billion	3.09 Billion	3.09 Billion	3.09 Billion	3.09 Billion	3.09 Billion
Retained Earnings	4.32 Billion	5.73 Billion	5.22 Billion	5.22 Billion	4.64 Billion	4.03 Billion
Accumulated other comprehensive income	3.92 Billion	3.25 Billion	2.94 Billion	2.94 Billion	3.35 Billion	3.11 Billion
Common Stock Equity	12.03 Billion	12.72 Billion	11.87 Billion	11.87 Billion	11.73 Billion	10.88 Billion
Capital Lease Obligation	7.4 Million	10.57 Million	6.71 Million	6.71 Million	34.1 Million	23.14 Million
Total Investments	2.43 Billion	1.03 Billion	2.18 Billion	2.18 Billion	1.15 Billion	1.19 Billion
Total Debt	5.03 Billion	4.39 Billion	4.01 Billion	4.01 Billion	4.27 Billion	3.72 Billion
Net Debt	-711.71 Million	167.14 Million	-290.95 Million	-290.95 Million	755.24 Million	-773.15 Million

Balance Sheet Charts

Ringer Hut Co., Ltd.

8200

Full Analysis

Annual Balance Sheets
Gudeng Precision Industrial Co., Ltd.

3680

Full Analysis

Annual Balance Sheets
Sinphar Pharmaceutical Co.,Ltd.

1734

Full Analysis

Annual Balance Sheets
Canaccord Genuity Group Inc.

CF-PC

Full Analysis

Annual Balance Sheets
Ravinder Heights Limited

RVHL

Full Analysis

Annual Balance Sheets
Extendicare Inc.

EXE

Full Analysis

Annual Balance Sheets

Global Stocks Search

TXC Corporation (3042.TW)

Annual Balance Sheets

Balance Sheet Charts

Ringer Hut Co., Ltd.

Gudeng Precision Industrial Co., Ltd.

Sinphar Pharmaceutical Co.,Ltd.

Canaccord Genuity Group Inc.

Ravinder Heights Limited

Extendicare Inc.